Scott F M, Modali R, Lehman T A, Seddon M, Kelly K, Dempsey E C, Wilson V, Tockman M S, Mulshine J L
Biomarkers and Prevention Research Branch, National Cancer Institute, Rockville, Maryland 20850, USA.
Clin Cancer Res. 1997 Mar;3(3):479-82.
A high frequency of K-ras mutations may indicate preneoplastic changes in the bronchial epithelium as a result of genotoxic injury. With the use of sensitive detection techniques, we report a higher prevalence of K-ras mutations in bronchoalveolar lavage than has been reported previously for lung cancer. A PCR/ligase chain reaction technique was used to determine K-ras codon 12 mutations in a group of 52 bronchoalveolar lavage specimens from patients at risk of a second lung cancer. Of the specimens examined, 84% contained at least one mutation in K-ras codon 12, corroborated by an allele-specific hybridization method. These results suggest that point mutations in K-ras codon 12 are widespread in the bronchial epithelium. Based on these preliminary findings, further evaluation of this efficient sensitive assay to monitor K-ras status should be conducted in larger clinical cohorts where clinical outcomes will ultimately be available. Such a trial will define the utility of K-ras codon 12 mutation status as a marker of lung cancer.
K-ras 突变的高频率可能表明由于基因毒性损伤,支气管上皮发生了癌前变化。通过使用灵敏的检测技术,我们报告支气管肺泡灌洗中 K-ras 突变的发生率高于先前报道的肺癌发生率。采用聚合酶链反应/连接酶链反应技术,对一组 52 例有二次肺癌风险患者的支气管肺泡灌洗标本进行 K-ras 密码子 12 突变检测。在检测的标本中,84%在 K-ras 密码子 12 中至少含有一个突变,等位基因特异性杂交方法证实了这一点。这些结果表明 K-ras 密码子 12 的点突变在支气管上皮中广泛存在。基于这些初步发现,应在最终可获得临床结果的更大临床队列中,对这种监测 K-ras 状态的有效灵敏检测方法进行进一步评估。这样的试验将确定 K-ras 密码子 12 突变状态作为肺癌标志物的效用。